Clinical Trial Update: A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravitreal injections of a small interfering RNA therapy for age-related macular degeneration was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Bevasiranib

Snippet

Sponsor: Allergan | Conditions: Choroid Neovascularization, Age-Related Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2011-12-13